We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$341M
AUM Growth
+$7.46M
Cap. Flow
-$14M
Cap. Flow %
-4.12%
Top 10 Hldgs %
56.58%
Holding
359
New
34
Increased
32
Reduced
64
Closed
30
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSM icon
151
TSMC
TSM
$2.18T
$34K 0.01%
420
CE icon
152
Celanese
CE
$4.82B
$33K 0.01%
310
GSK icon
153
GSK
GSK
$106B
$32K 0.01%
686
JPM icon
154
JPMorgan Chase
JPM
$950B
$32K 0.01%
331
+27
+9% +$2.65K
PAYC icon
155
Paycom
PAYC
$9.69B
$32K 0.01%
102
UL icon
156
Unilever
UL
$136B
$32K 0.01%
468
-120
-20% -$8.01K
VHT icon
157
Vanguard Health Care ETF
VHT
$18.6B
$32K 0.01%
155
VIOO icon
158
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.25B
$32K 0.01%
500
ETN icon
159
Eaton
ETN
$174B
$31K 0.01%
300
HBI
160
DELISTED
Hanesbrands
HBI
$30K 0.01%
1,890
NEA icon
161
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.42B
$30K 0.01%
2,078
BURL icon
162
Burlington
BURL
$23.2B
$29K 0.01%
143
OXY icon
163
Occidental Petroleum
OXY
$55.9B
$29K 0.01%
2,860
ADBE icon
164
Adobe
ADBE
$105B
$28K 0.01%
57
+39
+217% +$18.1K
AZN icon
165
AstraZeneca
AZN
$250B
$28K 0.01%
260
DBEF icon
166
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
$28K 0.01%
930
-35
-4% -$1.08K
MET icon
167
MetLife
MET
$62.1B
$28K 0.01%
740
WMT icon
168
Walmart Inc
WMT
$890B
$28K 0.01%
606
+3
+0.5% +$133
BKNG icon
169
Booking.com
BKNG
$161B
$26K 0.01%
375
IAU icon
170
iShares Gold Trust
IAU
$67.5B
$26K 0.01%
730
+461
+171% +$16.8K
MKTX icon
171
MarketAxess Holdings
MKTX
$5.72B
$26K 0.01%
55
STLD icon
172
Steel Dynamics
STLD
$37.6B
$25K 0.01%
864
VUG icon
173
Vanguard Morningstar Growth ETF
VUG
$231B
$25K 0.01%
666
TAN icon
174
Invesco Solar ETF
TAN
$1.49B
$24K 0.01%
374
TSLA icon
175
Tesla
TSLA
$1.3T
$24K 0.01%
165
-30
-15% -$3.54K

Similar funds

Roble Belko & Company's Q3 2020 Portfolio in Review

As of Q3 2020, Roble Belko & Company held 359 positions worth $341M, up 2.2% from $334M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Roble Belko & Company withdrew a net $14M in Q3 2020, closing 30 positions and reducing 64 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $303K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.2% of assets, up from 2% a quarter earlier, followed by Technology and Industrials.

Against the trend, Roble Belko & Company opened a new position in Vanguard Morningstar Mid-Cap Growth ETF worth $284K.

  • Roble Belko & Company's largest Q3 2020 buy was Vanguard Morningstar Mid-Cap Growth ETF: 1,578 shares worth $284K.
  • Roble Belko & Company added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q3 2020, an estimated $1.4M increase.
  • Roble Belko & Company's biggest Q3 2020 reduction was Global X MLP & Energy Infrastructure ETF, cutting an estimated $2.31M.
  • Roble Belko & Company fully exited State Street SPDR S&P Biotech ETF in Q3 2020, selling an estimated $303K.
  • Roble Belko & Company's ten largest holdings make up 57% of its $341M portfolio in Q3 2020.
  • Roble Belko & Company opened 34 new positions and closed 30 in Q3 2020.
  • Roble Belko & Company's portfolio value rose 2.2% quarter-over-quarter to $341M.

Based on Roble Belko & Company's 13F filing for Q3 2020, filed 10 Nov 2020.